Welcure Drugs & Pharmaceuticals plans to invest about ₹80 crore in setting up a modern Current Good Manufacturing Practice (cGMP) (regulatory standard) research laboratory dedicated for agro pharma research.
The size of the project is estimated to be around ₹70-80 crore, including laboratory infrastructure, pilot lines, analytics and quality systems.
The facilities and processes will be designed to align with applicable cGMP standards and the US FDA’s Botanical Drug Development guidance, in order to enable participation in broader international markets for botanical/ ayurvedic products, subject to all necessary approvals.
The proposed site, timeline and commissioning plan will be finalised post approvals. The lab will conduct research, validate and scale processes for conversion of agricultural/ botanical inputs into pharma-grade products aimed at public health and societal well being. The above proposals are subject to requisite Board, shareholder, regulatory and statutory approvals and market conditions.
Company proposes to raise up to ₹80 crore through Qualified Institutional Placement, in one or more tranches to fund the agro pharma research laboratory and for general corporate purposes.
Meeting of the Board of Directors will be held on August 28 to consider and approve the aforesaid fund-raising by QIP, including approving enabling resolutions, issue structure and seeking shareholders’ approval as may be required.
Published on August 20, 2025